<DOC>
	<DOCNO>NCT02210962</DOCNO>
	<brief_summary>There accumulate experimental evidence suggest role essential fatty acid ( EFA ) neuronal migration , prune synaptic plasticity . These process imply dysfunctional early stage schizophrenia , accord neurodevelopmental hypothesis . Numerous epidemiological clinical trial data support benefit EFA rich diet reduce symptom schizophrenia . An EFA rich diet might particular importance begin illness . As relatively safe option , EFA supplementation would preferable add therapy treat individual first episode schizophrenia ( FES ) short duration psychotic symptom . No long term follow-up study EFA supplementation FES patient carry . The demonstration efficacy prophylactic property EFAs relapse prevention FES patient would strong basis study prescribe EFAs large population patient early stage debilitate illness .</brief_summary>
	<brief_title>Omega-3 Fatty Acids Efficacy First-episode Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Patients diagnose schizophrenia use Diagnostic Statistical Manual Mental Disorders , fourth edition ( DSMIV ) criterion Patients age 1635 year Signed informed consent ( parallel parent consent individual 18 year age ) Patients take fish oil supplement ( washout period 6 month require ) Patients diagnose epilepsy suffer epileptic seizure Patients receive anticoagulant medication e.g. , Warfarin Patients receive psychotherapy Chronic somatic disease Psychoactive substance dependence Pregnancy lactation Mental retardation diagnose organic brain injury</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>early psychosis</keyword>
	<keyword>chronic schizophrenia</keyword>
	<keyword>first episode psychosis</keyword>
	<keyword>omega-3 omega-6 essential fatty acid</keyword>
	<keyword>relapse prevention</keyword>
	<keyword>efficacy</keyword>
</DOC>